Inhibitors of Akt activity
US7544677B2 · kind B2 · utility
9Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 19, 2005 |
| Grant date | Jun 9, 2009 |
| Priority date | — |
| Expiry date | Aug 20, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds which contain substituted 5-deazapteridine moieties which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.